Skip to content
drillr
.ai
Product
▼
Datasets
▼
Docs
(opens in a new tab)
Pricing
Research
Benchmark
Sign in
Sign up
4
4599.T
StemRIM Inc.
グロース
医薬品
医薬品
JP
グロース · 医薬品 · 医薬品 · JP
JPY 314.00
+0.32%
+ Watch
Ask drillr
Overview
Financials
Valuation
Profitability
Growth
Capital
Momentum
Earnings
Ownership
News
Analysis
Jul 9, 2026, 22:32 UTC
Stemrim obtained a patent in South Korea for a stem cell gene therapy for epidermolysis bullosa.
Source:
s.kabutan.jp